Hydroxychloroquine is a less dangerous chloroquine derivative. Hydroxychloroquine is an immunosuppressive and anti-parasite drug used to treat or prevent malaria, though it is ineffective against chloroquine-resistant malaria. When other medications fail to work or cannot be used, hydroxychloroquine is also recommended for autoimmune diseases such as systemic and discoid lupus erythematosus and rheumatoid arthritis (acute and severe).
Recently, hydroxychloroquine has gained popularity due to its efficacy in treating patients with coronavirus disease (COVID 19). According to Chinese reports, chloroquine may be able to inhibit SARS-CoV-2 in vitro. The drug was found to be effective in treating patients with coronavirus disease (COVID 19). Hydroxychloroquine is expected to be a promising potential coronavirus treatment (COVID 19).
Read more @ https://bit.ly/3pCYhnj
Source:
https://www.coherentmarketinsights.com/market-insight/hydroxychloroquine-market-3727
